MYLUNG Consortium Part 3: Observational Study

RecruitingOBSERVATIONAL
Enrollment

7,500

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Carcinoma, Non-Small-Cell Lung
Trial Locations (17)

12208

RECRUITING

New York Oncology Hematology, P.C., Albany

20904

ACTIVE_NOT_RECRUITING

Maryland Oncology Hematology, P.A., Silver Spring

22031

ACTIVE_NOT_RECRUITING

Virginia Cancer Specialists, PC, Fairfax

22601

ACTIVE_NOT_RECRUITING

Shenandoah Oncology, P.C., Winchester

23606

RECRUITING

Virginia Oncology Associates, Newport News

24060

RECRUITING

Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care, Blacksburg

32503

ACTIVE_NOT_RECRUITING

Woodlands Medical Specialists, PA, Pensacola

32901

RECRUITING

Cancer Care Centers of Brevard, Inc., Palm Bay

36526

RECRUITING

Southern Cancer Center, PC, Daphne

45242

RECRUITING

Oncology Hematology Care Clinical Trials, LLC, Cincinnati

55404

ACTIVE_NOT_RECRUITING

Minnesota Oncology Hematology, P.A., Minneapolis

60415

RECRUITING

Affiliated Oncologists, LLC, Chicago Ridge

60714

ACTIVE_NOT_RECRUITING

Illinois Cancer Specialists, Niles

80218

ACTIVE_NOT_RECRUITING

Rocky Mountain Cancer Center, Denver

86314

NOT_YET_RECRUITING

Arizona Oncology Associates, PC - NAHOA, Prescott Valley

97401

RECRUITING

Willamette Valley Cancer Institute and Research Center, Eugene

98684

RECRUITING

Northwest Cancer Specialists, P.C., Vancouver

All Listed Sponsors
lead

US Oncology Research

INDUSTRY